In one retrospective cohort study, conducted in 2021 at a large American multi-centre healthcare system in persons with rheumatic diseases who had received two doses of mRNA vaccine, breakthrough COVID-19 infections occurred more often in individuals using mycophenolate, methotrexate, rituximab, and tumor necrosis factor inhibitors [20]. The gene discussed is TNF; the disease is rheumatic disorder.